Minimal Invasive Treatment of Inguinal Hernia in Neonates

Sponsor
Maltepe University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05702710
Collaborator
(none)
40
1
1.9
20.6

Study Details

Study Description

Brief Summary

In this study, preoperative physical examination findings, peroperative findings and data, and postoperative follow-up results of newborns who underwent inguinal hernia repair with PIRS ("Percutaneous Internal Ring Suturing") method will be evaluated retrospectively.

Condition or Disease Intervention/Treatment Phase
  • Other: Surgery (PIRS)

Detailed Description

Congenital inguinal hernia is one of the most common surgical pathologies of childhood. Its treatment includes high ligation of the patent processus vaginalis by open or laparoscopic method. There are many described minimally invasive/laparoscopic repair techniques of inguinal hernias in children. One of them is "percutaneous internal ring suturing" or "Percutaneous Inner Ring Suturing".

There are many studies on the PIRS method in children. Two of these studies are prospective clinical studies published previously by the investigators of this study: in the first, the PIRS method was shown to be a safe and effective method for minimally invasive repair of inguinal hernia in children, and in the second, the use of subparalytic laryngeal masks in anesthesia of patients who underwent PIRS was shown to be sufficient for airway protection and anesthesia management in children undergoing laparoscopy.

Although there are many studies on the repair of inguinal hernia in children with PIRS or other minimally invasive methods in the last decade, there are very limited studies on the use of these methods in newborns, a special group of childhood patients. In the literature, there is no study examining only newborn patients. In this context, the study will be a first in the literature.

Study Design

Study Type:
Observational
Anticipated Enrollment :
40 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Percutaneous Internal Ring Suturing is a Safe and Effective Method in the Minimal Invasive Treatment of Inguinal Hernia in Neonates
Actual Study Start Date :
Jan 30, 2023
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Mar 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Neonates Undergoing PIRS

All children <28 days of age undergoing PIRS for inguinal hernia repair

Other: Surgery (PIRS)
Laparoscopic procedure for repair of inguinal hernia as described in: 1) Thomas DT, Göcmen KB, Tulgar S, Boga I. Percutaneous internal ring suturing is a safe and effective method for the minimal invasive treatment of pediatric inguinal hernia: Experience with 250 cases. J Pediatr Surg. 2016 Aug;51(8):1330-5. doi: 10.1016/j.jpedsurg.2015.11.024. Epub 2015 Dec 11. PMID: 26777889.
Other Names:
  • Percutaneous Internal Ring Suturing
  • Outcome Measures

    Primary Outcome Measures

    1. Surgery Time [Measured as time from skin prep until dressing is performed (approx. 20-30minutes)]

      Time from skin prep to end of dressing

    2. Anesthesia Time [Measured in minutes from induction to awakening (approx. 30-40minutes)]

      Time from induction to awakening

    3. Presence of Contralateral Patent Processus Vaginalis [Measured during surgery (approx. 5-10minutes)]

      Whether a patent processus vaginalis was observed and repaired on laparoscopy

    Secondary Outcome Measures

    1. Dose of Muscle Relaxant [Measured throughout surgery (20-30minutes)]

      None, Subparalytic or Paralytic

    2. Type of Airway Management Used [Measured throughout surgery (20-30minutes)]

      ETT (Endotracheal Tube) or LMA (Laryngeal Mask Airway)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Day to 28 Days
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Having undergone PIRS surgery at the study institute between October 1, 2015 and January 1, 2023

    2. Age between 0-28 days

    Exclusion Criteria:
    1. Age > 28 days

    2. Having had surgery with open surgery

    3. Having another surgical procedure performed in the same session

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Maltepe University Hospital Istanbul Turkey

    Sponsors and Collaborators

    • Maltepe University

    Investigators

    • Principal Investigator: David T Thomas, MD, Maltepe University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Assoc. Prof. David T. Thomas, M.D., Associate Professor, Maltepe University
    ClinicalTrials.gov Identifier:
    NCT05702710
    Other Study ID Numbers:
    • PIRS003
    First Posted:
    Jan 27, 2023
    Last Update Posted:
    Jan 31, 2023
    Last Verified:
    Jan 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 31, 2023